A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Joseph Zohar; Stephen Stahl; Hans Jurgen Moller; Pierre Blier; David Kupfer; Shigeto Yamawaki; Hiroyuki Uchida; Michael Spedding; Guy M. Goodwin; David Nutt

doi:10.1016/j.euroneuro.2015.08.019

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Joseph Zohar, Stephen Stahl, Hans Jurgen Moller, Pierre Blier, David Kupfer, Shigeto Yamawaki, Hiroyuki Uchida, Michael Spedding, Guy M. Goodwin, David Nutt

精神・神経科学

研究成果: Article › 査読

120 被引用数 (Scopus)

抄録

Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

本文言語	English
ページ（範囲）	2318-2325
ページ数	8
ジャーナル	European Neuropsychopharmacology
巻	25
号	12
DOI	https://doi.org/10.1016/j.euroneuro.2015.08.019
出版ステータス	Published - 2015 12月 1

ASJC Scopus subject areas

薬理学
神経学
臨床神経学
精神医学および精神衛生
生物学的精神医学
薬理学（医学）

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1016/j.euroneuro.2015.08.019

他のファイルとリンク

引用スタイル

@article{d713102f95d94c14bf27270d387e4f2b,

title = "A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature",

abstract = "Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.",

keywords = "Adherence, Mode of action, Neuroscience, Nomenclature, Pharmacological domain, Psychotropic drugs",

author = "Joseph Zohar and Stephen Stahl and Moller, {Hans Jurgen} and Pierre Blier and David Kupfer and Shigeto Yamawaki and Hiroyuki Uchida and Michael Spedding and Goodwin, {Guy M.} and David Nutt",

note = "Funding Information: This project was funded by the ECNP (Neutoscience-based-Nomenclature) . Publisher Copyright: {\textcopyright} 2015.",

year = "2015",

month = dec,

day = "1",

doi = "10.1016/j.euroneuro.2015.08.019",

language = "English",

volume = "25",

pages = "2318--2325",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

AU - Zohar, Joseph

AU - Stahl, Stephen

AU - Moller, Hans Jurgen

AU - Blier, Pierre

AU - Kupfer, David

AU - Yamawaki, Shigeto

AU - Uchida, Hiroyuki

AU - Spedding, Michael

AU - Goodwin, Guy M.

AU - Nutt, David

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

AB - Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

KW - Adherence

KW - Mode of action

KW - Neuroscience

KW - Nomenclature

KW - Pharmacological domain

KW - Psychotropic drugs

UR - http://www.scopus.com/inward/record.url?scp=84959851997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959851997&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2015.08.019

DO - 10.1016/j.euroneuro.2015.08.019

M3 - Article

C2 - 26527055

AN - SCOPUS:84959851997

SN - 0924-977X

VL - 25

SP - 2318

EP - 2325

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

IS - 12

ER -

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

抄録

ASJC Scopus subject areas

UN SDG

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル